These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22179563)

  • 1. Drug resistance to paclitaxel is not only associated with ABCB1 mRNA expression but also with drug accumulation in intracellular compartments in human lung cancer cell lines.
    Shimomura M; Yaoi T; Itoh K; Kato D; Terauchi K; Shimada J; Fushiki S
    Int J Oncol; 2012 Apr; 40(4):995-1004. PubMed ID: 22179563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATP-binding cassette B1 gene polymorphisms, mRNA expression and chemosensitivity to paclitaxel in non-small cell lung cancer cells.
    Meng X; Wang G; Liu P; Hou J; Jin Y; Yu Y; Bai J; Chen F; Sun W; Fu S
    Respirology; 2011 Nov; 16(8):1228-34. PubMed ID: 21883677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells.
    Ji N; Yang Y; Cai CY; Lei ZN; Wang JQ; Gupta P; Shukla S; Ambudkar SV; Kong D; Chen ZS
    Cancer Lett; 2019 Jan; 440-441():82-93. PubMed ID: 30315846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of ABCB1 (MDR1) and ABCB4 (MDR3) expression by small interfering RNA and reversal of paclitaxel resistance in human ovarian cancer cells.
    Duan Z; Brakora KA; Seiden MV
    Mol Cancer Ther; 2004 Jul; 3(7):833-8. PubMed ID: 15252144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
    Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
    Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-expression of LKB1 in LKB1-mutant EKVX cells leads to resistance to paclitaxel through the up-regulation of MDR1 expression.
    Mao K; Liu F; Liu X; Khuri FR; Marcus AI; Li M; Zhou W
    Lung Cancer; 2015 May; 88(2):131-8. PubMed ID: 25769882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combretastatin A-4 resistance in H460 human lung carcinoma demonstrates distinctive alterations in beta-tubulin isotype expression.
    Wehbe H; Kearney CM; Pinney KG
    Anticancer Res; 2005; 25(6B):3865-70. PubMed ID: 16309172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tubulin-targeted drug action: functional significance of class ii and class IVb beta-tubulin in vinca alkaloid sensitivity.
    Gan PP; Kavallaris M
    Cancer Res; 2008 Dec; 68(23):9817-24. PubMed ID: 19047161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of drug resistance by alpha-tubulin in paclitaxel-resistant human lung cancer cell lines.
    Han EK; Gehrke L; Tahir SK; Credo RB; Cherian SP; Sham H; Rosenberg SH; Ng S
    Eur J Cancer; 2000 Aug; 36(12):1565-71. PubMed ID: 10930805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells.
    Wang H; Vo T; Hajar A; Li S; Chen X; Parissenti AM; Brindley DN; Wang Z
    BMC Cancer; 2014 Jan; 14():37. PubMed ID: 24447372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of broad drug resistance in small cell lung cancer cells and its reversal by paclitaxel.
    Su GM; Davey MW; Davey RA
    Int J Cancer; 1998 May; 76(5):702-8. PubMed ID: 9610729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRP7/ABCC10 expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancer.
    Oguri T; Ozasa H; Uemura T; Bessho Y; Miyazaki M; Maeno K; Maeda H; Sato S; Ueda R
    Mol Cancer Ther; 2008 May; 7(5):1150-5. PubMed ID: 18445659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted inhibition of the HNF1A/SHH axis by triptolide overcomes paclitaxel resistance in non-small cell lung cancer.
    Li LB; Yang LX; Liu L; Liu FR; Li AH; Zhu YL; Wen H; Xue X; Tian ZX; Sun H; Li PC; Zhao XG
    Acta Pharmacol Sin; 2024 May; 45(5):1060-1076. PubMed ID: 38228910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low dose HSP90 inhibition with AUY922 blunts rapid evolution of metastatic and drug resistant phenotypes induced by TGF-β and paclitaxel in A549 cells.
    Bacon NA; Larre I; Lawag AA; Merritt C; Smith M; Rosolen M; Sollars VE
    Biomed Pharmacother; 2020 Sep; 129():110434. PubMed ID: 32768937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher sensitivity to patupilone versus paclitaxel chemotherapy in primary uterine serous papillary carcinoma cell lines with high versus low HER-2/neu expression in vitro.
    Paik D; Cocco E; Bellone S; Casagrande F; Bellone M; Siegel EE; Richter CE; Schwartz PE; Rutherford TJ; Santin AD
    Gynecol Oncol; 2010 Oct; 119(1):140-5. PubMed ID: 20673976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of patupilone resistance.
    Mozzetti S; Iantomasi R; De Maria I; Prislei S; Mariani M; Camperchioli A; Bartollino S; Gallo D; Scambia G; Ferlini C
    Cancer Res; 2008 Dec; 68(24):10197-204. PubMed ID: 19074887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer.
    Gan PP; Pasquier E; Kavallaris M
    Cancer Res; 2007 Oct; 67(19):9356-63. PubMed ID: 17909044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G-T haplotype (2677G>T/A and 3435C>T) of ABCB1 gene polymorphisms is associated with ethnic differences to paclitaxel sensitivity in cancer cells with different gene expression pattern.
    Kwon WS; Rha SY; Jeung HC; Ahn JB; Jung JJ; Noh SH; Chung HC
    Cancer Lett; 2009 May; 277(2):155-63. PubMed ID: 19138818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-(3,4,5-trimethoxybenzoyl)-4-methyl-2-(p-tolyl) imidazol (BZML) targets tubulin and DNA to induce anticancer activity and overcome multidrug resistance in colorectal cancer cells.
    Bai Z; Liu X; Guan Q; Ding N; Wei Q; Tong B; Zhao M; Zhang W; Ma L
    Chem Biol Interact; 2020 Jan; 315():108886. PubMed ID: 31682804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservation of the class I beta-tubulin gene in human populations and lack of mutations in lung cancers and paclitaxel-resistant ovarian cancers.
    Sale S; Sung R; Shen P; Yu K; Wang Y; Duran GE; Kim JH; Fojo T; Oefner PJ; Sikic BI
    Mol Cancer Ther; 2002 Jan; 1(3):215-25. PubMed ID: 12467216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.